The path to an angiotensin receptor antagonist-neprilysin inhibitor in the treatment of heart failure
about
Effect of Cardiac Resynchronization Therapy on Inflammation in Congestive Heart Failure: A ReviewSpotlight on valsartan-sacubitril fixed-dose combination for heart failure: the evidence to dateARNI: A New Paradigm for the Treatment of Heart Failure in Taiwan?Role of biomarkers in cardiac structure phenotyping in heart failure with preserved ejection fraction: critical appraisal and practical use.Heart failure trials on pharmacological therapy in 2015: lessons learned and future outlook.Renin-angiotensin-aldosterone system blockade in chronic kidney disease: current strategies and a look ahead.First-in-Class Composite Angiotensin Receptor-Neprilysin Inhibitors (ARNI) in Practice.The Future of Cardiovascular Regenerative Medicine.Kicking the tyres of a heart failure trial: physician response to the approval of sacubitril/valsartan in the USA.Neurohormonal activation in heart failure with reduced ejection fraction.Angiotensin-Neprilysin Inhibition as a Paradigm for All?Progress in the Presence of Failure: Updates in Chronic Systolic Heart Failure Management.The evolution of natriuretic peptide augmentation in management of heart failure and the role of sacubitril/valsartan.Angiotensin II Receptor-Neprilysin Inhibitor Sacubitril/Valsartan Improves Endothelial Dysfunction in Spontaneously Hypertensive Rats.Synthesis, secretion, function, metabolism and application of natriuretic peptides in heart failure.
P2860
Q27023183-B379F277-FF73-4705-AF9E-4EE35C73DF6FQ28070064-D2B50BBD-A05D-4B56-9542-B87DB796C800Q37131799-99FCB500-2F55-4AE9-BB99-5F98633F162BQ38614176-3467938E-F878-47C4-A331-4BF53870F9DAQ38754215-E43D8364-46B8-479D-9671-BF4064BC9B49Q38777543-5D62D8AC-D216-4A87-BC8F-C819C7683F35Q38781645-B7164538-EC17-4ED7-B8FE-047572B34D7BQ38850633-E02D9717-F43F-4225-BD75-989DCCB57362Q38924076-81595D1B-CD8F-4623-A2A8-4629797E0BCCQ38973209-990F0688-3EAD-404E-8E1D-9643B283368FQ38982213-F543D6C3-A54B-45B6-92E6-612049E06377Q39317320-D142364A-549C-41AC-BD40-2B3CF6A933F1Q41549636-C977A229-4B82-4CAF-B689-7264239246A0Q47231226-95144CEE-6249-4BB7-B3D5-268B53EAE06EQ47855200-BF5D490F-5BBE-44C7-BC32-152B413AF27F
P2860
The path to an angiotensin receptor antagonist-neprilysin inhibitor in the treatment of heart failure
description
2015 nî lūn-bûn
@nan
2015 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի մարտին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
The path to an angiotensin rec ...... the treatment of heart failure
@ast
The path to an angiotensin rec ...... the treatment of heart failure
@en
The path to an angiotensin rec ...... the treatment of heart failure
@nl
type
label
The path to an angiotensin rec ...... the treatment of heart failure
@ast
The path to an angiotensin rec ...... the treatment of heart failure
@en
The path to an angiotensin rec ...... the treatment of heart failure
@nl
prefLabel
The path to an angiotensin rec ...... the treatment of heart failure
@ast
The path to an angiotensin rec ...... the treatment of heart failure
@en
The path to an angiotensin rec ...... the treatment of heart failure
@nl
P3181
P1476
The path to an angiotensin rec ...... the treatment of heart failure
@en
P304
P3181
P356
10.1016/J.JACC.2015.01.033
P407
P577
2015-03-17T00:00:00Z